Effects of Rapamycin on the Activation and Growth of Primordial Follicles in Mice

Chen Xiuying,Guan Haiyun,Li Bin,Zhang Wei
DOI: https://doi.org/10.3760/cma.j.issn.2096-2916.2020.0015
2020-01-01
Abstract:Objective To investigate the effects of Rapamycin, a mammalian target of rapamycin (mTOR) specific inhibitor, on the activation and growth of primordial follicles in mice from the signal transduction of follicular development. Methods A total of 40 C57BL/6 female mice were randomly divided into control group (n=20, same volume of saline) and Rapamycin treatment group (n=20, 5 mg/kg Rapamycin). Seven mice in each group were treated after 30 d, and ovarian histomorphological changes were observed by HE staining, the expressions of DDx4/MVH and Ki-67 were detected by immunohistochemistry, the level of mTOR and its downstream molecules were detected by Western blotting. Eight weeks after administration, 6 mice in control group and Rapamycin treatment group were selected for follicle count, and the expressions of anti-Mullerian hormone (AMH) and Ki-67 were detected by immunohistochemistry. Another 7 mice of both groups were treated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG) for ovulation induction. The ovaries were obtained for histomorphological observation by HE staining. Results The number of primordial follicle in Rapamycin treatment group was significantly increased compared with control group (P=0.040), and a large number of primordial follicles were clustered, while the number of growing follicles was significantly decreased(P=0.002). The number of primordial follicle, expressing DDx4/MVH molecule, was increased, while the expression of Ki-67 was decreased compared with control group. Eight weeks after Rapamycin treatment, the number of primordial follicles was still more than that in control group, and the expressions of Ki-67 and AMH in growing follicles were normal. After ovulation induction treatment, large numbers of mature follicles or corpus luteum could be observed in both two groups. Western blotting showed that the phosphorylation levels of mTOR and its downstream molecules p70S6K, rpS6 and eIF4B in Rapamycin treated group were significantly lower than those in control group, while the total molecular level did not change significantly (P>0.05). Conclusion Rapamycin could inhibit the activation of primordial follicles by inhibiting the phosphorylation of mTOR signaling pathway, and slow down the transformation rate of primordial follicles to the growth follicles, and also inhibit the development of growing follicles, thus protect the ovarian reserve function.
What problem does this paper attempt to address?